贝贝林点的景观:对心力衰竭治疗的潜在药理洞察
Siao Wen1,2, Xiehong Liu1,2, Liping Liu1,2
1Department of Cardiology, the First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha 410000,China.
Journal of cardiovascular pharmacology
|August 20, 2025
概括
通过改善肠道健康和降低心脏风险, 柏柏林对心力衰竭治疗具有前景. 需要进一步的临床试验来证实它的有效性和安全性,特别是对于心力衰竭与保存的喷射分数 (HFpEF).
科学领域:
- 药理学和治疗学
- 心血管医学
- 微生物学与肠道健康
背景情况:
- 柏柏林是一种来自Coptis chinensis的化合物,具有多种药理作用,包括抗感染,低血糖和抗炎性质.
- 新兴研究强调肠心轴,强调肠道微生物群在心力衰竭的发病过程中的作用.
研究的目的:
- 在心力衰竭的背景下审查柏柏林的物理化学,药理动力学和药理动力学特性.
- 探索柏柏林的作用机制,包括它对肠道微生物群的影响和对心血管系统的直接影响.
- 通过网络药理学确定贝贝林用于心力衰竭治疗的关键分子标.
主要方法:
- 关于柏柏林对肠道微生物群,肠道屏障功能和心血管参数的影响的综合文献综述.
- 肠道和肠外药理作用的分析.
- 网络药理方法用于识别心力衰竭中的枢纽基因和治疗点.
主要成果:
- 柏柏林增强了肠道屏障的完整性,调节了肠道微生物群的组成 (例如,Bacillota/Bacteroidota比率),并改变了微生物代谢物 (减少TMAO,增加SCFA).
- 肠外作用包括减轻动脉样硬化和高血糖等危险因素,减少心脏压力 (氧化,ER),改善心肌能量代谢.
- 网络药理学确定了STAT3,TNF,MTOR,NFKB1,HIF1A,ESR1,BCL2,PTGS2,PPARG和MMP9作为关键基因;TNF,HIF1A和PPARG对于HFpEF治疗至关重要.
结论:
- 柏柏林通过对肠心轴和直接心脏机制的多方面的作用,显示出对心力衰竭的显著治疗潜力.
- 像TNF,HIF1A和PPARG这样的关键点在用保存的喷射分数 (HFpEF) 治疗心力衰竭方面具有特殊的有用性.
- 进一步的大规模临床试验对于验证贝贝林在临床心力衰竭治疗中的有效性,安全性和最佳使用,特别是对于HFpEF,以及解决其生物可用性挑战至关重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:22Heart Failure Drugs: β-Blockers
434
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
434
01:22Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
01:26Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
01:29Heart Failure II: Pathophysiology
38
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38